M. L. Cohen, R. W. Fuller, K. D. Kurz, Hypertension 1983, vol. 5, p. 676, Sep. 1983. |
H. Lal, P. L. Prather, S. M. Rezazadeh, Alcoholism: Clinical and Experimental Research, 1993, vol. 17, p. 411, Mar. 1993. |
R. A. Glennon, A. M. Ismalel, C. Chaurasia, M. Titeler, Drug Development Research 1991, vol. 22, p. 25, Jan. 1991. |
Nelson, David L., The Serotonin2 (5-HT2) Subfamily of Receptors: Pharmacological Challenges, Medicinal Chemistry Research, 1993, vol. 3, 306-316, Feb. 1993. |
Forbes, Ian T., et al., J. Med. Chem., 36:1104-1107 (1993). |
Leonard, B.E., International Clinical Psychopharmacology, 7:13-21 (1992). |
Fludzinski, P., Journal of Medicinal Chemistry, 29:2415-2418 (1986). |
Kalkman, H.O., Life Sciences, 54:641-644 (1994). |
Wainscott David B., Molecular Pharmacology, 43:419-426 (1993). |
Foguet M., et al., NeuroReport, 3:345-348 (1992). |
Cohen, Marlene L., et al., The Journal of Pharmacology and Experimental Theapeutics, 233:75-79, 770-774 (1985). |
Clineschmidt, Bradley V., et al., The Journal of Pharmacology and Experimental Therapeutics, 235:696-708 (1985). |
Cohen, Marlene L., et al., Life Sciences, 38:1-5 (1986). |